RHUMBLINE ADVISERS - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$113,000
-48.9%
138,373
+0.1%
0.00%
Q4 2018$221,000
-27.3%
138,271
+50.4%
0.00%
-100.0%
Q3 2018$304,000
+45.5%
91,964
-0.7%
0.00%
Q2 2018$209,000
+99.0%
92,635
+32.1%
0.00%
Q1 2014$105,000
-21.6%
70,111
-3.5%
0.00%
Q4 2013$134,000
-16.2%
72,641
-6.0%
0.00%
Q3 2013$160,000
-17.5%
77,241
-0.6%
0.00%
-100.0%
Q2 2013$194,00077,7140.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Deer VI & Co. LLC 675,242$2,465,000100.00%
New Leaf Venture Partners, L.L.C. 2,340,673$8,543,0003.96%
RA Capital Management 11,328,646$41,350,0003.74%
NEA Management Company, LLC 16,362,694$59,724,0002.09%
Avoro Capital Advisors LLC 4,806,249$17,543,0001.36%
683 Capital Management, LLC 2,515,810$9,183,0000.96%
SPHERA FUNDS MANAGEMENT LTD. 1,400,000$5,110,0000.73%
Perceptive Advisors 6,830,232$25,110,0000.48%
EAM Investors, LLC 785,338$2,866,0000.38%
Polar Capital LLP 4,129,238$15,072,0000.17%
View complete list of AVEO PHARMACEUTICALS INC shareholders